Correlation Between Arch Biopartners and NervGen Pharma
Can any of the company-specific risk be diversified away by investing in both Arch Biopartners and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arch Biopartners and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arch Biopartners and NervGen Pharma Corp, you can compare the effects of market volatilities on Arch Biopartners and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arch Biopartners with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arch Biopartners and NervGen Pharma.
Diversification Opportunities for Arch Biopartners and NervGen Pharma
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Arch and NervGen is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Arch Biopartners and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Arch Biopartners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arch Biopartners are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Arch Biopartners i.e., Arch Biopartners and NervGen Pharma go up and down completely randomly.
Pair Corralation between Arch Biopartners and NervGen Pharma
Assuming the 90 days trading horizon Arch Biopartners is expected to generate 0.55 times more return on investment than NervGen Pharma. However, Arch Biopartners is 1.81 times less risky than NervGen Pharma. It trades about 0.13 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.01 per unit of risk. If you would invest 158.00 in Arch Biopartners on September 12, 2024 and sell it today you would earn a total of 33.00 from holding Arch Biopartners or generate 20.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.44% |
| Values | Daily Returns |
Arch Biopartners vs. NervGen Pharma Corp
Performance |
| Timeline |
| Arch Biopartners |
| NervGen Pharma Corp |
Arch Biopartners and NervGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arch Biopartners and NervGen Pharma
The main advantage of trading using opposite Arch Biopartners and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arch Biopartners position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.| Arch Biopartners vs. NervGen Pharma Corp | Arch Biopartners vs. Nanalysis Scientific Corp | Arch Biopartners vs. Perimeter Medical Imaging | Arch Biopartners vs. Medicenna Therapeutics Corp |
| NervGen Pharma vs. Xunlei Ltd Adr | NervGen Pharma vs. Dolphin Entertainment | NervGen Pharma vs. Finnair Oyj | NervGen Pharma vs. CarsalesCom Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |